Pharmaceutical Executive September 30, 2024
Miranda Schmalfuhs

The latest news for pharma industry insiders.

Regulatory Concerns Associated With Utilizing RWD

In this video interview with ACT editor Andy Studna, Rich Gliklich, founder of OM1 highlights existing guidances on real-world data and where there is room for even more oversight.

Black Women With Breast Cancer Have Higher Risk of Death Compared With White Women

Study results showed that Black women with breast cancer were more likely to die across all subtypes, with the disparity varying from 17% to 50% depending on subtype.

‘We Are Not a Normal Company’: OpenAI’s Latest Drama

More high-level departures caught some at the high-flying A.I. start-up off guard, as the company seeks to raise billions to fund its operations and ambitious goals.

Next...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry

Share This Article